Interferon-l (IFN-l) is a central regulator of mucosal immunity; however, its signaling specificity relative to that of type I interferons is poorly defined. IFN-l can induce antiviral interferon-stimulated genes (ISGs) in epithelia, while the effect of IFN-l in non-epithelial cells remains unclear. Here we report that neutrophils responded to IFN-l. We found that in addition to inducing ISG transcription, IFN-l (but not IFN-b) specifically activated a translation-independent signaling pathway that diminished the production of reactive oxygen species and degranulation in neutrophils. In mice, IFN-l was elicited by enteric viruses and acted on neutrophils to decrease oxidative stress and intestinal damage. Thus, IFN-l acted as a unique immunomodulatory agent by modifying transcriptional and non-translational neutrophil responses, which might permit a controlled development of the inflammatory process.
A r t i c l e s
Interferons have long been used to scrutinize mechanisms of inflammation, metabolism and cancer. The interferon family comprises type I interferons (represented mainly by IFN-α and IFN-β), type II interferons (IFN-γ) and type III interferons (IFN-λ). Studies of interferon activity have centered on the ability of these cytokines to regulate the transcription and translation of ISGs, which in turn contributes to the enhanced detection of, and defense against, pathogens and to the re-establishment of normal homeostasis 1 . In contrast to the increasing knowledge of interferon-mediated expression of ISGs, it remains unclear whether immediate (transcription-independent) interferon responses are important physiologically, or even exist. Transcriptionindependent activity of the innate immune system is often-associated with an acute need for rapid host responses. For example, phagocytosis, reactive oxygen species (ROS) production and the degranulation of mast cells, cytotoxic T lymphocytes and neutrophils are all transcription-independent activities that permit the rapid clearance of pathogens or infected cells.
The need for rapid immune responses is most critical during the earliest stages of infection, at barrier surfaces. At barrier sites such as the lungs, liver and intestine, epithelia are the most-prominent stromal cells, and neutrophils are the most rapidly recruited immune cells. Among the interferon family of cytokines, IFN-λ is the only class whose activity is exerted mainly on barrier epithelial cells [2] [3] [4] [5] [6] [7] [8] [9] . Although the functions of some immune cells, such as phagocytes and lymphocytes [10] [11] [12] [13] [14] [15] [16] [17] [18] , have been reported to be modified by IFN-λ, the IFN-λ receptor IFNLR is expressed mainly on epithelial cells [2] [3] [4] [5] [6] [7] [8] [9] . IFNLR is a heterodimer composed of the ubiquitously expressed receptor chain IL-10RB and the epithelium-specific receptor chain IFNLR1 (refs. 19-21) . In contrast, the receptors for type I interferons (IFNAR) and for IFN-γ (IFNGR) are expressed by every cell type 1 .
Due to the specific importance of IFN-λ at barrier surfaces, we hypothesized that this class of cytokines would exhibit transcriptionindependent activities important for barrier homeostasis and defense. In our study, we found that neutrophils were the only immune cells that promptly responded to stimulation with IFN-λ. We showed that IFN-λ, but not type I interferons, regulated a non-translational signaling pathway independent of the STAT family of transcription factors that diminished neutrophil ROS production and degranulation but did not alter other protective activities, such as cytokine production or phagocytosis. Through the use of the mouse model of dextran sodium sulfate (DSS)-induced colitis, we found that IFN-λ protected mice against intestinal inflammation; this action of IFN-λ was totally independent of signaling in epithelial cells and relied solely on signaling in neutrophils. Also, we demonstrated that the presence of intestinal viruses was important for diminishing DSSinduced inflammation and that this effect was due to signaling by IFN-λ but not by type I interferons.
RESULTS

Mouse and human neutrophils express a functional IFNLR
We investigated the ability of various types of mouse immune cells to express mRNA encoding the two chains that form the IFNLR and to respond to stimulation with IFN-λ in terms of activation of ISG transcription. Neutrophils isolated on a Percoll gradient from the bone marrow ( Supplementary Fig. 1a ) had higher expression of Ifnlr1 than that of primary intestinal epithelial cells (Fig. 1a) and responded to IFN-λ by upregulating expression of the ISG Rsad2 (called 'Viperin' here) (Fig. 1b) . Next we investigated whether Ifnlr1 expression changed during neutrophil differentiation. The expression of Ifnlr1 and induction of Viperin in response to IFN-λ were lower in Ly6G int-hi SSC int immature neutrophils sorted from the bone marrow of wild-type C57BL/6 mice than in their Ly6G hi SSC hi mature counterparts ( Supplementary Fig. 1b-d) . Ly6G hi SSC hi mature neutrophils and Ly6G int-hi SSC int immature neutrophils had the same capacity to upregulate Viperin in response to stimulation with IFN-β (Supplementary Fig. 1d ). In addition, Ly6G + CD11b + neutrophils from the blood showed expression of Ifnlr1 similar to that of Ly6G hi SSC hi mature neutrophils from the bone marrow (either sorted or purified through the use of Percoll), while Ly6G + CD11b + neutrophils isolated from the peritoneal cavity after injection of thioglycollate had the highest expression of Ifnlr1 ( Supplementary  Fig. 1c ). Other innate and adaptive immune cells analyzed (conventional and plasmacytoid dendritic cells (DCs), T cells and B cells, and peritoneal macrophages) did not express Ifnlr1 and did not induce Viperin expression in response to recombinant IFN-λ (Fig. 1a,b and Supplementary Fig. 1e ). As expected, the cells analyzed induced Viperin expression in response to treatment with IFN-β (Fig. 1b) . In vitro administration of the pro-inflammatory cytokine TNF or lipopolysaccharide (LPS) did not alter the pattern of Ifnlr1 expression in DCs, macrophages or adaptive lymphocytes but increased the , left unstimulated or stimulated for 3 h with LPS (10 µg/ml) or TNF (100 ng/ml) (key). (d) qPCR analysis of Ifnlr1 (left) in human neutrophils left unstimulated or stimulated for 3 h with LPS (10 µg/ml), and of Viperin mRNA (right) in human neutrophils treated for 3 h with IFN-λ2 (100 U/ml) or IFN-β (100 U/ml) (horizontal axis) and left unstimulated or stimulated for 3 h with LPS (10 µg/ml) (key). (e) Immunoblot analysis of phosphorylated (p-) STAT1 and STAT3, and β-actin (loading control throughout), in neutrophils derived from the bone marrow of wild-type mice (top) or Ifnlr1 −/− mice (bottom) and stimulated for 0-60 min (above lanes) with IFN-λ or IFN-β (blots cropped to show bands of the appropriate molecular size). (f) NanoString analysis of gene expression (nCounter Mouse Inflammation v2 panel; genes modulated more than twofold, with a P value of > 0.05) in mouse neutrophils stimulated for 30 min, 1 h or 3 h (left margin) with IFN-λ or IFN-β (100 U/ml). Data are from one of three experiments (a; mean + s.e.m. of three biological replicates) or one experiment representative of three experiments (b,d; mean + s.e.m. of three biological replicates) or are representative of three independent experiments (c,e,f; mean + s.e.m. in c).
1 0 8 6 VOLUME 18 NUMBER 10 OCTOBER 2017 nature immunology A r t i c l e s expression of Ifnlr1 in neutrophils (Fig. 1c) . That was in agreement with the observation that neutrophils isolated from the peritoneum after the administration of thioglycollate (which induces an inflammatory state) had higher expression of Ifnlr1 than that of bloodderived neutrophils (Supplementary Fig. 1c ). Human neutrophils isolated from the blood of healthy donors via gradient centrifugation, Fig. 1e ). NS, not significant (P > 0.05); *P < 0.05, **P < 0.01 and ***P < 0.001 (unpaired two tailed t-test). Data are representative of (a (left and
, c (left), e) three independent experiments (mean + s.e.m.).
A r t i c l e s
for the isolation of human polymorphonuclear leucocytes, had low basal expression of IFNLR1 but upregulated their VIPERIN transcription when challenged with recombinant human IFN-λ2 in vitro (Fig.  1d) . Similar to mouse neutrophils, human neutrophils upregulated their IFNLR1 expression following activation with LPS ( Fig. 1d) . These data demonstrated that mouse and human neutrophils were unique among the immune cells we assessed in their ability to respond to IFN-λ stimulation in resting and inflammatory conditions. To define the function of IFN-λ in neutrophils, we compared the ability of IFN-β and IFN-λ to induce the activation of specific STAT proteins and found that both types of interferons induced phosphorylation of STAT1-STAT3 in neutrophils, even though IFN-λ-induced phosphorylation of all the STAT proteins analyzed was less robust than that induced by IFN-β ( Fig. 1e and Supplementary Fig. 1f ), consistent with data from epithelial cells [22] [23] [24] . The specificity of STAT phosphorylation in response to the administration of IFN-λ was confirmed through the use of neutrophils derived from IFNLR1-deficient mice (Fig. 1e) . We next investigated by NanoString technology the effect of stimulation with IFN-β or IFN-λ on gene expression at various time points (0.5, 1 and 3 h) in neutrophils freshly isolated from the bone marrow of wild-type mice. Analysis of a NanoString probe panel containing a pool of more than 190 genes encoding products associated with the inflammatory response indicated that all the genes modulated more than twofold (P < 0.05) were co-regulated by IFN-λ and IFN-β (Fig. 1f) . Overall, these data indicated that neutrophils sensed IFN-λ and induced classic IFN-β-like ISG responses.
IFN-l regulates neutrophil function independently of transcription
To investigate whether neutrophils exhibited transcription-independent interferon responses, we assessed neutrophil ROS production and release of granule contents 25 in an inflammatory context. Treatment with IFN-λ substantially reduced the capacity of human and mouse neutrophils to release ROS in response to stimulation with TNF or LPS, compared with that of neutrophils stimulated with TNF or LPS alone (without interferon treatment) (Fig. 2a,b) , in a dose-and timedependent manner ( Supplementary Fig. 2a-c ), but treatment with IFN-β did not. To determine if neutrophil degranulation was affected by IFN-β or IFN-λ, we assessed the enzymatic activity of the tertiary granule component MMP-9 by measuring degradation of gelatin. Treatment with IFN-λ resulted in deficient MMP-9 activity relative to that of wild-type cells stimulated with LPS alone, but not relative to that of IFNLR1-deficient neutrophils stimulated with LPS alone ( Fig. 2c and Supplementary Fig. 2d ), suggestive of impaired degranulation. In contrast, treatment with IFN-β resulted in more gelatin degradation than that of neutrophils treated with LPS only ( Supplementary  Fig. 2d ), suggestive of increased degranulation. Next, we activated wild-type neutrophils from the bone marrow with LPS in the presence or absence of IFN-λ, or not, and assessed their supernatants for the presence of lactate dehydrogenase (LDH), an enzyme that is released when the integrity of the plasma membrane is altered. LDH levels were similar under all the conditions tested ( Supplementary Fig. 2e ), which excluded the possibility that the secretion of MMP-9 was due to passive release of cytoplasm contents. Neutrophil viability was very similar under all these conditions, as assessed by staining of the apoptosis marker annexin V and with the membrane-impermeable DNAintercalating dye 7-AAD ( Supplementary Fig. 3a) , which indicated that interferon treatment did not alter in the lifespan of these neutrophils. Neutrophils isolated from the bone marrow of wild-type mice were treated with either IFN-λ or IFN-β or no interferon and were exposed to opsonized or non-opsonized Escherichia coli expressing green-fluorescent-protein (GFP). The 'GFP positivity' of neutrophils was assessed by cytofluorimetry and was used as a measurement of the phagocytic capacity of neutrophils. No difference was detected in in the GFP positivity of neutrophils treated with either IFN-λ or IFN-β or no interferon (Supplementary Fig. 3b) . Similarly, there were no differences in the secretion of TNF or the cytokines IL-10 or IL1-β from neutrophils treated with either IFN-β or IFN-λ or no interferon in the presence or absence of LPS (Supplementary Fig. 3c ). These data suggested that treatment with IFN-λ did not lead to a general suppression of the immunological function of neutrophils. NanoString analysis of the inflammation-related gene transcripts in wild-type bone marrow neutrophils activated with LPS in the presence or absence of either IFN-λ or IFN-β showed that IFN-β induced a gene-transcription profile similar to that induced by IFN-λ in the absence of LPS (Fig. 1f) or in its presence (Supplementary Fig. 3d ). These data indicated that IFN-β and IFN-λ exerted distinct effects on ROS production and degranulation by neutrophils while transcriptionally regulating the same set of genes.
To assess the dependence of the IFN-λ-induced inhibition of ROS production and degranulation on new protein synthesis, we treated wild-type bone marrow neutrophils with cycloheximide, which blocks protein synthesis. To assess the effectiveness of this treatment, we then treated neutrophils with puromycin, which binds to newly synthesized proteins and allows assessment of new protein synthesis. Immunoblot analysis of total proteins extracted from neutrophils with antibody to puromycin indicated that treatment with cycloheximide effectively blocked translation and the subsequent incorporation of puromycin (Supplementary Fig. 4a) . However, the IFN-λ-induced decrease in ROS production ( Fig. 2d and Supplementary Fig. 4b ) and A r t i c l e s Figs. 2d and 4c) was not affected by cycloheximide in wild-type bone marrow neutrophils activated with TNF or LPS. Next we focused on the transcriptional regulation of IFN-λ function. STAT1 is a master regulator of interferon-induced transcription of ISGs 26 . In wild-type bone marrow neutrophils treated with fludarabine, an inhibitor of STAT1, treatment with IFN-λ resulted in less ROS production than that of neutrophils treated with TNF (Supplementary Fig. 4d) . Similar results were obtained with STAT1-deficient neutrophils (Fig. 2e) . Increasing evidence has indicated nontranscriptional roles for STAT3 in determining several immunological functions [27] [28] [29] , and STAT3 was activated in wild-type bone marrow neutrophils in response to IFN-λ ( Fig. 1e and Supplementary Fig. 1f) . However, STAT3 deficiency did not alter the capacity of IFN-λ to diminish ROS production in neutrophils (Fig. 2e) .
MMP-9 activity (Supplementary
Jak kinases are activated following stimulation with IFN-λ, and the only difference described so far in the signaling pathway downstream of IFN-β and IFN-λ is the ability of IFNLR, but not of IFNAR, to recruit Jak2 (ref. 30). RAW264.7 mouse macrophages transfected with a construct that allows expression of the IFNLR1 chain acquired the ability to respond to IFN-λ, and stimulation with IFN-λ, or with IFN-γ, led to phosphorylation of Jak2 in these cells, but stimulation with IFN-β did not (Supplementary Fig. 4e ). In wild-type bone marrow neutrophils, Py6 (pyridone-6), an inhibitor of all Jak kinases, abolished the ability of IFN-λ to inhibit ROS production following activation with either TNF or LPS ( Fig. 2f and Supplementary Fig. 4f ). In addition, the Jak2 inhibitors HBC (1,2,3,4,5,6-hexabromocyclohexane) and AG490 also abolished the ability of IFN-λ to down-modulate ROS production in wild-type bone marrow neutrophils activated with TNF or LPS ( Fig. 2g and Supplementary Fig. 4g ). These data indicated that Jak2 mediated the IFN-λ-induced inhibitory effect on ROS production in neutrophils. To address the effectiveness of Jak2 and inhibition of all Jak kinases, we analyzed the ability of neutrophils to transcribe Viperin in response to IFN-λ or IFN-β, in the presence of either HBC or Py6. As expected, inhibition of all Jak kinases by Py6 reduced the induction of Viperin in response to either interferon, while inhibition of Jak2 by HBC affected the induction of Viperin only in response to IFN-λ (Supplementary Fig. 4h ). In addition, the phosphorylation of Jak2 in the IFNLR1-expressing RAW264.7 macrophages described above was impaired when these cells were stimulated with IFN-λ in the presence of HBC, relative to that of cells treated with IFN-λ alone (Supplementary Fig. 4e) .
To gain further insight into the molecular mechanisms that are regulated by IFN-λ and underlie the inhibition of the Jak2-mediated tissue-damaging functions of neutrophils, we investigated the key pathways known to be involved in neutrophil activation. The production of ROS by neutrophils is dependent on assembly of the NADPH oxidase 2 (NOX2) complex 31 . Phosphorylation of the NOX2 component p47 phox drives the translocation of p67 phox , p40 phox and RAC to cellular membranes, where they join NOX2 and the NOX2 component p22 phox to form an active enzyme. Phosphorylation of p47 phox by the kinase PKC 32 or the kinase AKT 33, 34 is required for the activation of NADPH oxidases, while the phosphorylation of p47 phox by the mitogen-activated protein kinases p38 and ERK1/2 (ref. 35) results in enhancement of this effect. The phorbol ester PMA potently activates PKC and largely bypasses the other requirements that lead to the activation of NOX2. PMA-induced production of ROS was similar in wild-type bone marrow neutrophils treated with IFN-λ and those not treated with IFN-λ (Supplementary Fig. 4i) . Also, treatment with IFN-λ did not alter formation of the Rac-p67 phox complex, either before or after stimulation with LPS (Supplementary Fig. 4j) .
Next, we analyzed by immunoblot the phosphorylation of AKT and p38, and of STAT1, as a control. We found p38 was phosphorylated similarly in the presence or absence of IFN-λ in LPS-treated neutrophils (Fig. 2h) , which excluded the possibility that the activation of mitogen-activated protein kinases was altered by treatment with IFN-λ. However, treatment with IFN-λ induced a potent reduction in the phosphorylation of AKT at Ser473 and Thr308 (Fig. 2h) . The phosphorylation of AKT was similar in IFN-λ-treated neutrophils and untreated neutrophils in the presence of the Jak2 inhibitor HBC (Fig. 2h) , which indicated that IFN-λ diminished neutrophil function via Jak2-dependent inhibition of the AKT pathway. Together these data indicated that the effects of IFN-λ on ROS production and degranulation in neutrophils were independent of protein synthesis or transcription and were dependent on inhibition of the activation of AKT.
IFN-l diminishes intestinal inflammation
We next investigated the effect of IFN-λ in DSS-induced colitis, a model of inflammation that depends on the activation of innate immune cells. Wild-type and IFNLR1-deficient mice co-housed 2 weeks before as well as during the experiment were given 2.5% DSS in their drinking water for 7 d. IFNLR1-deficient mice had a significantly shorter colon and lower weight, as well as a greater overall disease score, than that of wild-type mice at 7 d after the administration of DSS (Fig. 3a-c) , results that we confirmed by histological analysis (Fig. 3d) . Although the treatment of neutrophils with IFN-λ partially diminished their migratory ability in vitro (Supplementary Fig. 5a ), in confirmation of published observations 15 , the number of neutrophils present in the lamina propria of IFNLR-deficient mice was similar to that of wild-type mice at all time points assessed ( Supplementary  Fig. 5b) , which excluded the possibility that the diminished inflammatory state was caused by an inability of neutrophils to reach the inflamed tissue. Similarly, we detected no substantial difference in the amount of mRNA encoding the pro-inflammatory cytokines TNF Figure 4 The protective effect of IFN-λ in DSS-induced colitis is independent of the genetic background or strain-specific microbiota. Colitis in wild-type mice left treated with various combinations (keys and axes) of 2.5% DSS in their drinking water (DSS) or not (− DSS) and daily intraperitoneal injection of antibody to IFN-λ (α-IFN-λ) (10 g/kg) or not (no Ab), assessed as body weight (a), colon length (b), histopathological score (c) and histology (d). Scale bars (d), 500 µm. *P < 0.05, **P < 0.01 and ***P < 0.001 (two-way ANOVA (a,b) or nonparametric two-tailed t-test (c)). Data are from one experiment representative of three independent experiments (mean + s.e.m. of five mice in a-c).
A r t i c l e s or IL-6 in the colon of IFNLR-deficient mice and that in the colon of wild-type mice (Supplementary Fig. 5c,d) , or in the frequency of live neutrophils that infiltrated the colon of these mice ( Supplementary  Fig. 5e ). Analysis of the gene-transcription profile of the colon did not detect a significant difference between wild-type and IFNLR-deficient mice ( Supplementary Fig. 5f and Supplementary Table 1) . DSStreated IFNLR1-deficient mice showed more transcription of genes encoding anti-oxidant molecules in total colon extracts than did their wild-type counterparts (Fig. 3e) . In addition, wild-type mice treated with a blocking antibody to IFN-λ2 and IFN-λ3 showed a more robust increase in intestinal inflammation than that of untreated mice (Fig.  4) , which indicated that the greater tissue damage and oxidative stress were not caused by differences in the microbiota composition. Overall, our data supported the conclusion that IFN-λ has a crucial role in diminishing intestinal inflammation.
IFN-l acts on neutrophils to curtail intestinal inflammation
We next investigated the cell type that mediated the protective effect exerted by IFN-λ during intestinal inflammation. At 7 d after the administration of DSS, only neutrophils had high expression of Ifnlr1 in the lamina propria (Supplementary Fig. 6a ). We generated bonemarrow chimeras by transferring wild-type bone-marrow cells into irradiated wild-type recipient mice (WT→WT) or by transferring IFNLR1-deficient (Ifnlr1 −/− (IFNLR1-KO)) bone marrow cells into irradiated wild-type recipient mice (IFNLR1-KO→WT) (chimerism analysis, Supplementary Fig. 6b,c) , then co-housed the chimeras for 2 weeks and then treated them with 2.5% DSS in the drinking water for 7 d. IFNLR1-KO→WT chimeras had a significantly shorter colon, more tissue damage and weight loss and a higher pathology score when challenged with DSS than did WT→WT chimeras (Fig. 5a-c and Supplementary Fig. 6d) . The intestinal epithelial cells of IFNLR1-KO→WT chimeras showed oxidative-stress-induced upregulation of gene expression and more direct oxidative damage to DNA than that of WT→WT chimeras ( Fig. 5d and Supplementary Fig. 6e) .
Notably, even though IFNLR was expressed by epithelial cells in IFNLR1-KO→WT chimeras (data not shown), epithelial cells in those mice showed more oxidative stress than that of epithelial cells in WT→WT chimeras (Fig. 5d) , which suggested that the absence of IFN-λ signaling in neutrophils had a dominant influence on tissue damage and oxidation.
To further investigate whether neutrophils have a unique role in protecting mice against DSS-induced inflammation, we used MRP8 cre Ifnlr1 fl/fl C57BL/6 mice, in which expression of Cre recombinase under the control of the promoter of the human gene encoding the myeloid-cell co-regulator MRP8 selectively ablates the loxPflanked second exon of Ifnlr1 (Ifnlr1 fl/fl ) in neutrophils 36 . Accordingly, neutrophils derived from MRP8 cre Ifnlr1 fl/fl C57BL/6 mice did not express Ifnlr1 mRNA (Supplementary Fig. 6f ) and did not respond to stimulation with IFN-λ (Supplementary Fig. 6g ). MRP8 cre Ifnlr1 fl/fl C57BL/6 mice recapitulated the phenotype seen in the IFNLR1-KO→WT chimeras (Fig. 5e-h and Supplementary Fig. 6h ). The recruitment of neutrophils to the lamina propria of MRP8 cre Ifnlr1 fl/fl C57BL/6 mice was similar to that of Ifnlr1 fl/fl C57BL/6 (control) mice ( Supplementary  Fig. 6i ). NanoString gene-expression analysis of MRP8 cre Ifnlr1 fl/fl C57BL/6 and Ifnlr1 fl/fl C57BL/6 mice 9 d after the administration of DSS excluded the possibility of major differences in gene transcription in either neutrophils or stromal cells isolated from the inflamed colons ( Supplementary Fig. 6j and Supplementary Table 2) , suggestive of a non-transcriptional and non-translational effect of IFN-λ. Although we cannot rule out the possibility that under inflammatory conditions, immune cells other than the ones we assessed (DCs, macrophages, natural killer cells, neutrophils, group 3 innate lymphoid cells, T cells and B cells) might acquire IFNLR1 expression and responsiveness to IFN-λ in vivo, overall our data indicated that IFN-λ signaling in neutrophils mediated the diminished colon shortening, tissue damage and oxidative stress.
Because IFN-λ has a critical role in modifying epithelial-cell responses 3,4,19,36 , we induced DSS-mediated colitis in irradiated A r t i c l e s IFNLR1-deficient host mice reconstituted with wild-type bone marrow (WT→IFNLR1-KO), which lack IFNLR expression in the stromal compartment (Supplementary Fig. 6k,l) . We found that tissue damage, colon length, weight loss, disease score, oxidative stress mRNA response or oxidative damage to DNA were not significantly different in WT→IFNLR1 KO chimeras versus WT→WT (control) chimeras (Fig. 6a-g ). Because those data did not exclude the possibility of confounding effects of other non-immune cells or radio-resistant immune cells, we induced DSS-mediated colitis in Vil cre Ifnlr1 fl/fl C57BL/6 mice, in which Ifnlr1 is deleted in the intestinal epithelial cell compartment via Cre expressed from the promoter of the mouse gene encoding the actin-modifying protein villin-1 (Vil1) 36 ( Supplementary Fig. 6m ). We saw no major difference between Vil cre Ifnlr1 fl/fl C57BL/6 mice and Ifnlr1 fl/fl C57BL/6 (control) mice in terms of tissue damage, colon length, weight loss, disease score or oxidative stress (Fig. 6h-k and Supplementary Fig. 6n ). Together these data documented that IFN-λ signaling in neutrophils had a dominant role in diminishing tissue damage in the DSS-induced inflammatory model and favored the development of a regulated inflammatory response.
Enteric viruses protect against colitis via induction of IFN-l
Enteric viruses are reported to have a protective role in the development of DSS-induced intestinal inflammation 37 . Because viral stimulation potently triggers the induction of IFN-λ in the intestine 2-6,38 , we investigated whether IFN-λ contributes to the protective role of enteric viruses. To test this hypothesis, we administered a 'cocktail' of anti-viral (AV) drugs to wild-type, IFNLR1-deficient or IFNAR-deficient C57BL/6 mice intragastrically for 10 d, followed by the induction of colitis via DSS. Such treatment with AV drugs reduced the number of enteric virus-like particles recovered from the stool and inhibited the induction of IFN-λ in the intestine of DSS-treated wild-type C57BL/6 mice relative to that of mice treated with DSS alone (without AV drugs) (Supplementary Fig. 7a,b) . The dysbiosis caused by treatment with AV drugs significantly decreased colon length and augmented tissue damage in wild-type mice but not in IFNLR1-deficient mice (Fig. 7a-e) . Like DSS-treated wildtype mice, DSS-treated IFNAR-deficient mice were sensitive to the administration of AV drugs and showed greater tissue damage (as proven by their shorter colon length and higher disease activity index and by histological analysis), as well as greater oxidative stress, relative to that of mice given DSS but not treated with AV drugs, while no substantial alteration in Tnf expression in the colon was detected (Supplementary Fig. 7c-i) . These data indicated that in the absence of IFN-λ signaling, but not in the absence of IFN-α-IFN-β signaling, enteric viruses failed to protect the host against the development of intestinal inflammation. The administration of mouse recombinant IFN-λ to which polyethylene glycol was attached (Fig. 7e-i) , or commercially available recombinant IFN-λ (Supplementary Fig. 8a-c) , to wild-type A r t i c l e s mice treated with AV drugs diminished the colon shortening, tissue damage, weight loss and disease activity after treatment with DSS, which indicated that the protective role of enteric viruses could be mimicked by exogenous IFN-λ. Both exogenous IFN-β and exogenous IFN-λ protected mice treated with AV drugs from DSS-induced inflammation, but IFN-λ was more efficient in this ( Fig. 8a-d) . In addition, the inflamed intestinal tissues showed a similar gene signature, as measured by qPCR or NanoString technology, when either IFN-β or IFN-λ was administered (Fig. 8e,g and Supplementary Table 1) . However, only treatment with IFN-λ led to a robust reduction in ROS-dependent gene transcription in the epithelial cells of DSS-treated wild-type mice, relative to such transcription in their counterparts given DSS but not treated with IFN-λ (Fig. 8f) . Overall, our data suggest that enteric viruses protect their hosts against the development of colitis via the induction of a translation-independent program elicited by IFN-λ (Supplementary Fig. 8d ).
DISCUSSION
Here we have described a unique ability of IFN-λ to diminish the most potent tissue-damaging functions of neutrophils in a nontranscriptional and non-translational manner and have reported that these interferons curtailed intestinal inflammation. The ability to respond to IFN-λ was not limited to terminally differentiated (Ly6g hi SSC hi ) bone marrow neutrophils, as blood and peritoneal neutrophils also responded to stimulation by IFN-λ. Moreover, bloodderived human neutrophils showed activation of the same processes described for mouse neutrophils. These findings are particularly relevant in the context of using IFN-λ as a potential therapeutic agent. We found that IFN-λ regulated the activation of AKT in a JAK2-dependent manner to diminish ROS production by neutrophils. We excluded the possibility that IFN-λ altered the activation of p38, the RAC-p67 phoxdependent formation of the NOX2 complex or PKC function. Instead, IFN-λ profoundly decreased the activation of AKT, and this effect depended on the unique ability of IFN-λ (not type I interferons) to activate JAK2. 
A r t i c l e s
The most specific effects of IFN-λ signaling regulated non-translational events in neutrophils, relative to the effects of type I interferons. We found that neutrophils treated with cycloheximide, which blocks protein synthesis, as well as neutrophils stimulated in the presence of the STAT inhibitor fludarabine, were sensitive to the anti-inflammatory effects of IFN-λ. Similarly, neutrophils deficient in STAT1, a master regulator of the interferon-dependent induction of ISGs, or STAT3, which has been shown to have non-transcriptional roles, were also sensitive to treatment with IFN-λ. Although we cannot rule out the possibility of a contribution of interferon-dependent gene transcription in vivo during DSS-induced colitis, as has been suggested in the context of viral lung infection 39 , our data suggest a unique, translational-independent role for IFN-λ, in contrast to the role of type I interferons.
Finally, our observations indicated that enteric viruses facilitated protection against intestinal inflammation via the production of IFN-λ. In addition, although exogenously applied type I interferons have a protective role, the newly described ability of IFN-λ to diminish oxidative stress greatly potentiated its effectiveness in decreasing intestinal inflammation.
Our data have provided a mechanism by which the IFN-λ class of interferons regulate intestinal inflammation. Published literature has addressed the role of IFN-λ in epithelial-cell responses in the context of intestinal inflammation, but little is known about the ability of this class of interferons in modulating the function of immune cells. However, mutations in the gene encoding IL-10RB, which forms the IFNLR dimer, together with IFNLR1, are associated with the early onset of inflammatory bowel disease (IBD) 40, 41 , and loss of IL-10RB in innate immune cells results in the development of IBD 42 . Both observations suggest that the IFN-λ class of interferons probably participate in the development of IBDs. Indeed, it has been reported that patients with IBD show an altered profile of IFN-λ expression 43 . We anticipate that the previously unknown functions of the IFN-λ class of interferons and its limited cellular targets that we have documented here will inform future studies evaluating the possible relevance of these interferons in the context of the development of IBD.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. genes that generated >500 counts per treatment) in mRNA (100 ng) purified from total colon extracts of mice as in a-d. *P < 0.05, **P < 0.01 and ***P < 0.001 (two-way ANOVA.). Data are from one of three independent experiments (mean + s.e.m. of five mice per group in a-c,e,f).
cDNA, RAW cell line transfection and retrovirus-mediated gene transduction. The cDNA encoding full-length mouse Ifnlr1 (Accession: BC057856; Cat. MMM1013-202767950) was purchased from openbiosystems (Darmacon). A 3xHA tag was introduced to the C terminus of Ifnlr1 by PCR. For making RAW stable cell lines, IFNLR1-3HA was cloned into pMSCV2.2-IRES-hCD2. Retrovirus expressing the appropriate alleles was produced by 293T cells co-transfected with the packaging system composed of pVSVG, pCL-Eco and pMSCV vectors. RAW cells expressing IFNLR1-3HA were subjected for sorting by flow cytometry to an extent that 85% of the cells were positive for human CD2 in comparison to the untransduced parental cell lines.
Neutrophil isolation and functional assays. Naive neutrophils from the bone marrow of wild-type or Ifnlr1 −/− mice were purified over a 62.5% Percoll gradient (GE Healthcare) in Ca 2+ -and Mg 2+ -free HBSS as previously described 44 . Purified neutrophils, unless specified otherwise, were pre-treated, or not, with 100 U/ml of either IFN-λ or IFN-β for 30 min in HBSS supplemented with 20 mM HEPES at 37 °C at a density of 3 × 10 6 cells per ml before stimulation. Where indicated, neutrophils were sorted from bone marrow of wild-type mice based on the expression of Ly6G and SSC intensity. Mature neutrophils were sorted as Ly6G hi SSC hi cells, while immature neutrophils were sorted as Ly6G int-hi SSC int cells. Blood neutrophils were sorted as Ly6G + CD11b + cells from mouse blood, after red-blood-cell lysis. Peritoneal PMNs were sorted from peritoneal lavage of mice treated for 24 h with 1 ml 4% thioglycollate.
Human neutrophils were isolated from blood according to Boston Children's Hospital Institutional Review Board (IRB), protocol number IRB-P00022885. In brief, blood neutrophils were purified on a gradient of Polymorphprep (Axis Shield) according to the manufacturer's instruction. For functional assays, 3 × 10 5 neutrophils were plated on 96-well plates coated for 1 h at 37 °C with 150 µg/ml human fibrinogen (Millipore). Neutrophils were stimulated with 10 µg/ml LPS or 100 ng/ml TNF.
For extracellular ROS production, neutrophils were mixed with 100 mM cytochrome C (Sigma, Cat No. C-7752) before stimulation. To measure superoxide release, the difference in absorbance of the oxidized form of cytochrome C (550 nm) and the background absorbance of the non-reduced form (540 nm) was measured every two minutes in a Fluster Omega Microplate Reader.
To evaluate degranulation, supernatants from neutrophils stimulated as described above were collected and assessed by a zymography assay for gelatinase (MMP-9). Non-reducing sample buffer (10% glycerol (v/v), 2% SDS (w/v), 5 mg/ml bromophenol blue and 62.5 mM Tris, pH 6.8) was added to cell supernatants. Cell supernatants were then separated by SDS-PAGE in a 7.5% gel supplemented with 1 mg/ml gelatin (Sigma). Gels were subsequently renaturated in 10% Triton (Sigma) for 30 min and developed overnight in 200 mM NaCl, 5mM CaCl 2 and 50 mM Tris, pH 7.4. Gels were stained with Coomassie blue and images of the gel were generated by scanning. MMP-9 activity was quantified with Image-J software.
Migration experiments were performed with Transwell inserts with 3-µm diameter pores (Corning), coated with 150 µg/ml fibrinogen. 5 × 10 5 neutrophils were seeded on the top of the Transwell and 1 µM fMLP was used as a chemoattractant. Migrated cells were counted on the bottom of the Transwell after 60 min of incubation at 37 °C with CasyCounter (Innovatis).
To evaluate cytokine production 3 × 10 5 neutrophils were plated in 96-well plates and were stimulated overnight with 10 µg/ml LPS in DMEM (GIBCO) supplemented with 10% FBS (GIBCO). Production of TNF and IL-10 was evaluated in the supernatants by ELISAmax (BioLegend) according to the manufacturer's specifications. IL-1β production was evaluated as both cell associated and secreted IL-1β by freezing of the cells along with the supernatants twice at −80 °C. After thawing, IL-1β was measured using Mouse Ready-SET-Go ELISA kit (e Bioscience) according to themanufacturer's instructions.
For phagocytosis experiments, E.coli (DH5α) expressing enhanced GFP (eGFP) was grown to an optical density (OD) of 1 in LB medium. E. coli was subsequently opsonized, or not, in HBSS with 10% mouse serum for 30 min at 37 °C. 1 × 10 5 purified neutrophils pre-treated or not with IFN-λ or IFN-β, were then incubated with E. coli at an multiplicity of infection of 1 for 30 min. Cells were then washed and analyzed by flow cytometry. The percentage of GFP + Ly6G + neutrophils was evaluated.
For NanoString nCounter assays, 1 × 10 4 neutrophils were either stimulated with 100 U/ml of IFN-λ2 or IFN-β or pre-treated in the same conditions and subsequently stimulated with LPS (10 µg/ml).
At the appropriate time points, neutrophils were lysed in RLT buffer and were hybridized onto nCounter Mouse Inflammation v2 cartridges on the nCounter Prep Station in triplicates according to the manufacturer's instructions. Hybridized cartridges were then read with the nCounter Digital Analyzer and analyzed by nSolver software (NanoString Technologies, Seattle, WA).
Evaluation of oxidative damage to DNA. DNA was extracted from 10 µg of colon tissue with a Purelink Genomic DNA mini Kit (Invitrogen) following the manufacturer's instructions. 50 ng of DNA was then reduced to single nucleotide. After denaturation (10 min at 90 °C), DNA was digested with 20 U of nuclease P1 (30 min at 50 °C in Tris-HCl, pH 5.5) and was dephosphorylated with 20 U of alkaline phosphatase (30 min at 37 °C in Tris-HCl, pH 7).
Single nucleotides thus obtained were tested for the presence of 8-oxoguanine using a DNA/RNA Oxidative Damage ELISA kit (#589320, Cayman) following the manufacturer's instruction.
Statistical analysis.
Statistical significance for experiments with more than two groups was tested with one-way ANOVA, and Tukey's multiple-comparison tests were performed. Two-way ANOVA with Tukey's multiple-comparison test was used to analyze kinetic experiments. To establish the appropriate test, normal distribution and variance similarity were assessed with the D' AgostinoPearson omnibus normality test using Prism7 (Graphpad) software.
When comparisons between only two groups were made, an unpaired two tailed t-test was used to assess statistical significance.
To determine the sample size, calculations were conducted in nQuery Advisor Version 7.0. Primary outcomes for each proposed experiment were selected for the sample size calculation and sample sizes adequate to detect differences with an 80% power were selected. For animal experiments, five to ten mice per group were used, as indicated in the figure legends.
Adjusted P values were calculated with Prism7 (Graphpad). Asterisks were used as follows (also indicated in figure legends): *P < 0.05, **P < 0.01, ***P < 0,001 and ****P < 0,0001.
A Life Sciences Reporting Summary for this paper is available.
Data availability statement. The data that support the findings of this study are available from the corresponding author upon request (in particular, the gating strategy used for all flow cytometry, and full-length gels and blots, as well as all raw data from NanoString analyses).
